Previous close | 0.6199 |
Open | 0.6400 |
Bid | 0.0000 x N/A |
Ask | 0.0000 x N/A |
Day's range | 0.6400 - 0.6400 |
52-week range | 0.2900 - 2.1105 |
Volume | |
Avg. volume | 47,193 |
Market cap | 796,729 |
Beta (5Y monthly) | 1.44 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
RICHMOND, Calif., March 22, 2024--SANGAMO THERAPEUTICS ANNOUNCES PRICING OF $24.0 MILLION REGISTERED DIRECT OFFERING
RICHMOND, Calif., March 13, 2024--Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
RICHMOND, Calif., March 13, 2024--SANGAMO ANNOUNCES DATA FROM PROPRIETARY NEUROTROPIC AAV CAPSID DEMONSTRATING INDUSTRY-LEADING BLOOD-BRAIN BARRIER PENETRATION & BRAIN TRANSDUCTION